Bioequivalence study of two formulations of a sitagliptin/metformin hydrochloride extended-release tablet in healthy Chinese subjects under fasting and fed conditions: a randomized, open-label, single-dose, crossover trial
Introduction This study aimed to evaluate the bioequivalence and safety of a newly developed generic sitagliptin/metformin hydrochloride extended‐release (XR) tablet (50 mg/500 mg) compared with the reference formulation, Janumet XR, in healthy Chinese subjects under fasting and fed conditions. Methods This randomized,...